Literature DB >> 15863631

Deciphering the "matrix" in pulmonary vascular remodelling.

P M Hassoun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863631     DOI: 10.1183/09031936.05.00027305

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Activation of proMMP-2 by U46619 occurs via involvement of p(38)MAPK-NFκB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells.

Authors:  Animesh Chowdhury; Soumitra Roy; Tapati Chakraborti; Kuntal Dey; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

Review 2.  Transdifferentiation of endothelial cells to smooth muscle cells play an important role in vascular remodelling.

Authors:  Núria Coll-Bonfill; Melina Mara Musri; Victor Ivo; Joan Albert Barberà; Olga Tura-Ceide
Journal:  Am J Stem Cells       Date:  2015-03-15

3.  Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension.

Authors:  Anita Umesh; Omkar Paudel; Yuan-Ning Cao; Allen C Myers; James S K Sham
Journal:  J Vasc Res       Date:  2011-08-10       Impact factor: 1.934

4.  Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.

Authors:  Leah R Villegas; Dylan Kluck; Carlie Field; Rebecca E Oberley-Deegan; Crystal Woods; Michael E Yeager; Karim C El Kasmi; Rashmin C Savani; Russell P Bowler; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2013-02-05       Impact factor: 8.401

5.  Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling.

Authors:  Nesrine El-Bizri; Lingli Wang; Sandra L Merklinger; Christophe Guignabert; Tushar Desai; Takashi Urashima; Ahmad Y Sheikh; Russell H Knutsen; Robert P Mecham; Yuji Mishina; Marlene Rabinovitch
Journal:  Circ Res       Date:  2007-12-13       Impact factor: 17.367

Review 6.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 7.  Pulmonary vascular mechanics: important contributors to the increased right ventricular afterload of pulmonary hypertension.

Authors:  Zhijie Wang; Naomi C Chesler
Journal:  Exp Physiol       Date:  2013-05-10       Impact factor: 2.969

8.  Hypertensive rat lungs retain hallmarks of vascular disease upon decellularization but support the growth of mesenchymal stem cells.

Authors:  Michelle E Scarritt; Ryan W Bonvillain; Brian J Burkett; Guangdi Wang; Elana Y Glotser; Qiang Zhang; Mimi C Sammarco; Aline M Betancourt; Deborah E Sullivan; Bruce A Bunnell
Journal:  Tissue Eng Part A       Date:  2014-02-28       Impact factor: 3.845

9.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

10.  NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.

Authors:  Isabel Diebold; Andreas Petry; Maximilian Burger; John Hess; Agnes Görlach
Journal:  Mol Biol Cell       Date:  2011-09-30       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.